| Location: | Coventry, University of Warwick |
|---|---|
| Salary: | £35,608 to £46,049 per annum. |
| Hours: | Full Time |
| Contract Type: | Fixed-Term/Contract |
| Placed On: | 10th December 2025 |
|---|---|
| Closes: | 6th January 2026 |
| Job Ref: | 3611 |
About the Role
For informal enquiries, please contact Fern Terris-Prestholt (Professor) at Fern.Terris-Prestholt@warwick.ac.uk.
The 10-10-10 UNAIDS targets aim for “Less than 10% of countries have punitive legal and policy environments that deny access to justice; less than 10% of people living with HIV and key populations experience stigma and discrimination; less than 10% of women, girls, people living with HIV and key populations experience gender inequality and violence.” (UNAIDS 2021). However, there is a dearth of cost-effectiveness evidence to inform policies and interventions around the most effective and efficient approaches to achieving these targets. The TransformHIV project, which is funded through a Wellcome Trust Discovery Award and led by University of Bristol, aims to address this critical evidence gap. It includes systematic reviews, epidemiological analyses, community leadership, mathematical modelling and economics to inform cost effectiveness of addressing structural barriers to HIV.
Applications are invited for a health economist to work with the project’s health economics lead, Prof Fern Terris-Prestholt based within Warwick Applied Health at Warwick Medical School, and the broader multi-disciplinary team. The health economist (you) will build from different intervention scenarios to estimate the direct, indirect, and societal costs and benefits of addressing structural barriers to HIV and the cost of inaction. Your work will directly inform global and national policy and advocacy to address structural barriers to HIV, something that is critically important in these turbulent times where funding for the HIV response is shifting from international donors to domestic resources. While the current global health financing in the short run emphasises maintaining essential services, we must not lose sight that without addressing structural barriers, we cannot end AIDS as a public health threat.
There is significant scope for academic creativity in developing the best economic evaluation methods, for example, primary costing, cost modelling, econometrics, discrete choice experiments to inform these societal cost benefit analyses. Likely interventions to be evaluated include those aiming to address stigma and discrimination, violence, and criminalisation among all key populations and homelessness among people who inject drugs.
You will be encouraged to undertake ongoing training and develop skills to undertake high-quality empirical and methodological research in health economics. You will be expected to contribute to a growing team of global health researchers and health economists across Warwick Medical School. There will also be opportunities to participate more broadly in the Medical School’s portfolio of health economics research and be a member of both Warwick Centre for Global Health and the Centre of Health Economics at Warwick.
Flexible Working
Full details of the duties and selection criteria for this role can be found in the vacancy advert on the University of Warwick's jobs pages. You will be routed to this when you click on the 'Apply' button.
CLOSING DEADLINE: Tuesday, 6th January 2025 at 11:55pm (UK Time).
Type / Role:
Subject Area(s):
Location(s):